+499.5%
MRNA vs MTCH
+13.9%
+485.6%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MTCH | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.3% | -0.9% | -1.1% |
| 7D | +5.5% | +0.7% | +4.8% | +4.9% |
| 30D | +158.7% | +9.7% | +149.0% | +143.4% |
| 3M | +182.1% | +21.1% | +161.1% | +154.1% |
| 6M | +151.8% | +37.5% | +114.3% | +116.0% |
| YTD | +393.6% | +31.9% | +361.6% | +329.2% |
| 1Y | +499.5% | +14.6% | +484.9% | +402.5% |
| All | +499.5% | +13.9% | +485.6% | +402.5% |
Cumulative growth
Daily Returns
Daily percentage return beside MTCH.
Daily Out/Under-Performance
Portfolio return minus MTCH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MTCH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MTCH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling